Using Bioinformatics Tools to Identify New Treatment Strategy for Non Small Cell Lung Cancer

by Peter Mu-Hsin Chang, 張牧新
Published 2013

Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics

by Jiun-I Lai, Jiun-I Lai, Jiun-I Lai, Yu-Jhen Tseng, Ming-Huang Chen, Ming-Huang Chen, Ming-Huang Chen, Chi-Ying F. Huang, Peter Mu-Hsin Chang, Peter Mu-Hsin Chang, Peter Mu-Hsin Chang
Published 2020-11-01

AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway

by Wei-Min Chang, Yu-Chan Chang, Yi-Chieh Yang, Sze-Kwan Lin, Peter Mu-Hsin Chang, Michael Hsiao
Published 2019-06-01

Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast c...

by Jia-Hong Chen, Wen-Chien Huang, Oluwaseun Adebayo Bamodu, Peter Mu-Hsin Chang, Tsu-Yi Chao, Tse-Hung Huang
Published 2019-06-01

Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer

by Chien-Hung Huang, Peter Mu-Hsin Chang, Yong-Jie Lin, Cheng-Hsu Wang, Chi-Ying F. Huang, Ka-Lok Ng
Published 2014-01-01

Oncogene inference optimization using constraint-based modelling incorporated with protein expression in normal and tumour tissues

by Wu-Hsiung Wu, Fan-Yu Li, Yi-Chen Shu, Jin-Mei Lai, Peter Mu-Hsin Chang, Chi-Ying F. Huang, Feng-Sheng Wang
Published 2020-03-01

Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathway

by Tsung-Ching Lai, Chih-Yeu Fang, Yi-Hua Jan, Hsiao-Ling Hsieh, Yi-Fang Yang, Chun-Yu Liu, Peter Mu-Hsin Chang, Michael Hsiao
Published 2020-10-01

Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer

by Hsueh-Ju Lu, Chao-Chun Yang, Ling-Wei Wang, Pen-Yuan Chu, Shyh-Kuan Tai, Ming-Huang Chen, Muh-Hwa Yang, Peter Mu-Hsin Chang
Published 2015-01-01

Cisplatin-Based Chemotherapy versus Cetuximab in Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer Treatment

by Ming-Hung Hu, Ling-Wei Wang, Hsueh-Ju Lu, Pen-Yuan Chu, Shyh-Kuan Tai, Tsung-Lun Lee, Ming-Huang Chen, Muh-Hwa Yang, Peter Mu-Hsin Chang
Published 2014-01-01

Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis

by Yu-Chan Chang, Li-Hsing Chi, Wei-Ming Chang, Chia-Yi Su, Yuang-Feng Lin, Chi-Long Chen, Ming-Huang Chen, Peter Mu-Hsin Chang, Alex T. H. Wu, Michael Hsiao
Published 2017-01-01

Gene Expression Profiling and Pathway Network Analysis Predicts a Novel Antitumor Function for a Botanical-Derived Drug, PG2

by Yu-Lun Kuo, Chun-Houh Chen, Tsung-Hsien Chuang, Wei-Kai Hua, Wey-Jinq Lin, Wei-Hsiang Hsu, Peter Mu-Hsin Chang, Shih-Lan Hsu, Tse-Hung Huang, Cheng-Yan Kao, Chi-Ying F. Huang
Published 2015-01-01

Transcriptome analysis and prognosis of ALDH isoforms in human cancer

by Peter Mu-Hsin Chang, Che-Hong Chen, Chi-Chun Yeh, Hsueh-Ju Lu, Tze-Tze Liu, Ming-Huang Chen, Chun-Yu Liu, Alexander T. H. Wu, Muh-Hwa Yang, Shyh-Kuan Tai, Daria Mochly-Rosen, Chi-Ying F. Huang
Published 2018-02-01

Flux balance analysis predicts Warburg-like effects of mouse hepatocyte deficient in miR-122a.

by Hua-Qing Wu, Mei-Ling Cheng, Jin-Mei Lai, Hsuan-Hui Wu, Meng-Chun Chen, Wen-Huan Liu, Wu-Hsiung Wu, Peter Mu-Hsin Chang, Chi-Ying F Huang, Ann-Ping Tsou, Ming-Shi Shiao, Feng-Sheng Wang
Published 2017-07-01

Gene expression-based chemical genomics identifies potential therapeutic drugs in hepatocellular carcinoma.

by Ming-Huang Chen, Wu-Lung R Yang, Kuan-Ting Lin, Chia-Hung Liu, Yu-Wen Liu, Kai-Wen Huang, Peter Mu-Hsin Chang, Jin-Mei Lai, Chun-Nan Hsu, Kun-Mao Chao, Cheng-Yan Kao, Chi-Ying F Huang
Published 2011-01-01

Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway

by Shin-Yi Chung, Yi-Ping Hung, Yi-Ru Pan, Yu-Chan Chang, Chiao-En Wu, Dennis Shin-Shian Hsu, Peter Mu-Hsin Chang, Meng-Lun Lu, Chi-Ying F. Huang, Yeu Su, Michael Hsiao, Chun-Nan Yeh, Ming-Huang Chen
Published 2021-07-01

PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy

by Shu-Jen Chen, Jen-Hao Cheng, Kien Thiam Tan, Chun-Nan Yeh, Yu-Chan Chang, Wen-Liang Fang, Yi-Chen Yeh, Yu-Chao Wang, Dennis Shin-Shian Hsu, Chiao-En Wu, Jiun-I Lai, Peter Mu-Hsin Chang, Ming-Han Chen, Meng-Lun Lu, Michael Hsiao, Ming-Huang Chen
Published 2020-06-01

A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of 188Re-liposome in patients with metastatic tumors

by Shyh-Jen Wang, Wen-Sheng Huang, Chi-Mu Chuang, Chih-Hsien Chang, Te-Wei Lee, Gann Ting, Ming-Huang Chen, Peter Mu-Hsin Chang, Ta-Chung Chao, Hao-Wei Teng, Yee Chao, Yuh-Min Chen, Tzu-Ping Lin, Ya-Jen Chang, Su-Jung Chen, Yuan-Ruei Huang, Keng-Li Lan
Published 2019-05-01